MLN-0415

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMLN-0415
Drug Alias NameMLN-0415SAR-479746
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of NF-kappa-B kinase (IKK) inhibitors
TargetsInhibitor of NF-kappa-B kinase (IKK)
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMillennium Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiMillennium Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A